Essure a novel option for the treatment of hydrosalpinx: a case series and literature review

被引:10
作者
Lorente Gonzalez, Juan [1 ]
Rios Castillo, Jose Enrique [1 ]
Pomares Toro, Elvira [1 ]
Romero Nieto, Maria Inmaculada [1 ]
Castelo-Branco, Camil [2 ]
Arjona Berral, Jose Eduardo [1 ]
机构
[1] Reina Sofia Univ Hosp, Dept Obstet & Gynecol, Cordoba, Spain
[2] Univ Barcelona, Hosp Clin, Fac Med, Inst Invest Biomed August Pi & Sunyer IDIBAPS,Ins, Barcelona, Spain
关键词
Assisted reproductive technology; Essure; hydrosalpinx; infertility; live-birth rate; IN-VITRO FERTILIZATION; ULTRASOUND-GUIDED ASPIRATION; PROXIMAL TUBAL OCCLUSION; PREGNANCY RATES; HYSTEROSCOPIC PLACEMENT; MICRO-INSERTS; IVF-ET; SALPINGECTOMY; IMPLANTATION; OUTCOMES;
D O I
10.3109/09513590.2015.1103221
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: The aim of this study is to evaluate the use of hysteroscopic Essure device placement for the treatment of hydrosalpinx (HS)-related infertility in patients with laparoscopic contraindications and compared their pregnancy outcomes following IVF-ICSI treatment with those patients having had laparoscopic tubal occlusion (LTO). Patients: From 2008 to 2014 a total of 50 patients were diagnosed with unilateral or bilateral hydrosalpinges: 29 patients had laparoscopic contraindications and were treated hysteroscopically and 21 patients were treated with laparoscopical salpingectomy. Results: Of the 29 patients who underwent treatment with Essure (R), 21 began a cycle of in vitro fertilization (IVF), and 13 finished in embryo transfer that resulted in seven clinical pregnancies. Furthermore, in the group of women treated with salpingectomy, 17 started an IVF cycle that resulted in 12 clinical pregnancies. The clinical pregnancy rate per patient with an IVF cycle started was 33.3% and 70.6%, the live-birth rate per patient was 14.3% and 52.9%, the miscarriage rate was 57.1% and 18.2%, and the implantation rate was 16.3% and 34.1% for hysteroscopy and laparoscopy, respectively. Conclusion: Essure (R) placement is an alternative method for occlusion of hydrosalpinges before IVF. Monitoring the live-birth rate confirms that this option may be considered when laparoscopy is impossible or contraindicated.
引用
收藏
页码:166 / 170
页数:5
相关论文
共 39 条
[1]  
Akman MA, 1996, HUM REPROD, V11, P1013
[2]   Essure® and chronic pelvic pain: A population-based cohort [J].
Arjona Berral, J. E. ;
Rodriguez Jimenez, B. ;
Velasco Sanchez, E. ;
Povedano Canizares, B. ;
Monserrat Jordan, J. ;
Lorente Gonzalez, J. ;
Castelo-Branco, C. .
JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2014, 34 (08) :712-713
[3]  
Arora P, 2013, BJOG, V121, P527
[4]   Pregnancy rates after in-vitro fertilization in cases of tubal infertility with and without hydrosalpinx: a meta-analysis of published comparative studies [J].
Camus, E ;
Poncelet, C ;
Goffinet, F ;
Wainer, B ;
Merlet, F ;
Nisand, I ;
Philippe, HJ .
HUMAN REPRODUCTION, 1999, 14 (05) :1243-1249
[5]   Hydrosalpinx and infertility: what about conservative surgical management? [J].
Chanelles, Olivier ;
Ducarme, Guillaume ;
Sifer, Christophe ;
Hugues, Jean-Noel ;
Touboul, Cyril ;
Poncelet, Christophe .
EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2011, 159 (01) :122-126
[6]   Does previous salpingectomy improve implantation and pregnancy rates in patients with severe tubal factor infertility who are undergoing in vitro fertilization?: A pilot prospective randomized study [J].
Déchaud, H ;
Daurès, JP ;
Arnal, F ;
Humeau, C ;
Hédon, B .
FERTILITY AND STERILITY, 1998, 69 (06) :1020-1025
[7]   Female subfertility [J].
Evers, JLH .
LANCET, 2002, 360 (9327) :151-159
[8]   Ultrasound guided aspiration of hydrosalpinx fluid versus salpingectomy in the management of patients with ultrasound visible hydrosalpinx undergoing IVF-ET: a randomized controlled trial [J].
Fouda, Usama M. ;
Sayed, Ahmed M. ;
Abdelmoty, Hatem I. ;
Elsetohy, Khaled A. .
BMC WOMENS HEALTH, 2015, 15
[9]   Utilization of the Essure® micro-insert for the treatment of hydrosalpinx prior to in vitro fertilization [J].
Galen, D. I. .
FERTILITY AND STERILITY, 2007, 88 :S16-S16
[10]   Essure Multicenter Off-Label Treatment for Hydrosalpinx Before In Vitro Fertilization [J].
Galen, Donald I. ;
Khan, Naveed ;
Richter, Kevin S. .
JOURNAL OF MINIMALLY INVASIVE GYNECOLOGY, 2011, 18 (03) :338-342